Inflammatory diseases don’t boost clotting risks post-COVID, study reveals

Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don’t face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care.

ADHD found to increase crash risk among older driving adults

The association between ADHD and car crash risk among older adult drivers.

October 5, 2023

Spesolimab by Boehringer Ingelheim International for Crohn’s Disease (Regional Enteritis): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 27, 2023

Virtual reality distracts from chronic pain while boosting exercise

Boosting exercise is often on the agenda in the new year, but if you’re struggling to stick to a new fitness regime, University of South

January 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.